Macerich Co - Prospectus filed pursuant to Rule 424(b)(7) (424B7)
November 19 2007 - 4:59PM
Edgar (US Regulatory)
Filed Pursuant to Rule 424(b)(7)
Registration No. 333-130993
PROSPECTUS
SUPPLEMENT NO. 11
(To Prospectus Dated January 12, 2006 and
Prospectus Supplements Dated June 7, June 21, June 29, July 19, August 6,
August 20, September 6, September 21, October 9 and November 6, 2007)
|
|
|
10,428,558 Shares
Common Stock
|
This prospectus supplement supplements the prospectus
dated January 12, 2006 and the prospectus supplements dated June 7, June 21,
June 29, July 19, August 6, August 20, September 6, September 21, October 9 and
November 6, 2007 relating to the offer and sell from time to time of up to 10,428,558 shares
of common stock of The Macerich Company by the selling stockholders named
therein. This number of shares includes
191,263 shares held by selling stockholders that were acquired upon redemption
of Units of The Macerich Partnership, L.P. and 10,237,295 shares constituting
the maximum number of shares of our common stock that could be issued upon
conversion of $950,000,000 aggregate principal amount of our 3.25 % Convertible
Senior Notes due 2012 (the Notes), subject to certain adjustments.
Investing
in the common stock involves risks. See Risk
Factors beginning on page S-2 of the prospectus supplement dated June 7,
2007.
We will not receive any proceeds from the
sale by the selling stockholders of the common stock. We will pay all expenses of the registration
of the common stock and certain other expenses.
Neither the
Securities and Exchange Commission nor any state securities commission has
approved or disapproved of these securities, or determined if this prospectus
supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a
criminal offense.
The date of this
prospectus supplement is November 19, 2007.
The information appearing under the heading Selling
Stockholders in the prospectus supplement dated June 7, 2007 and in the
prospectus supplements dated June 21, June 29, July 19, August 6, August 20,
September 6, September 21, October 9 and November 6, 2007 is hereby
supplemented and, as appropriate, amended by the following information. The number of shares of our common stock
indicated for the listed selling stockholders may be in excess of the 10,428,558
shares to which this prospectus relates due to sales or transfers by selling
stockholders of the Notes in transactions exempt from the registration
requirements under the Securities Act of 1933 after the date on which the
selling stockholders provided us with information regarding their holdings of
Notes.
Selling Stockholder
|
|
Shares Prior
to the
Offering
|
|
Shares Available
for Sale Under
this Prospectus
Supplement
|
|
Shares Afte
Completion of
the Offering(1)
|
|
|
|
|
|
|
|
|
|
Akanthos Arbitrage Master Fund L.P.
|
|
692,338
|
|
538,805
|
|
153,533
|
|
DBAG London(2)
|
|
1,049,753
|
|
1,049,753
|
|
0
|
|
dbx-Convertible Arbitrate 12 Fund
|
|
3,523
|
|
3,523
|
|
0
|
|
Institutional Benchmark Series (Master Feeder)
Limited in Respect of Electra Series
|
|
22,414
|
|
22,414
|
|
0
|
|
Lyxor/Quattro Fund Limited
|
|
5,980
|
|
5,980
|
|
0
|
|
Quattro Fund Ltd.
|
|
162,837
|
|
162,837
|
|
0
|
|
Quattro Multistrategy Masterfund LP
|
|
13,006
|
|
13,006
|
|
0
|
|
|
|
|
|
|
|
|
|
(1)
Assumes all
shares available for sale under this prospectus supplement are sold.
(2)
The selling
stockholder has stated that it is an affiliate of Deutsche Bank Securities,
Inc., a registered broker-dealer, and that it acquired beneficial ownership of
the Notes relating to the shares of common stock listed for the selling
stockholder in the ordinary course of business and, at the time of purchase,
did not have any agreements, understandings or arrangements, directly or
indirectly, with any person to distribute such Notes.
Macerich (NYSE:MAC)
Historical Stock Chart
From Jun 2024 to Jul 2024
Macerich (NYSE:MAC)
Historical Stock Chart
From Jul 2023 to Jul 2024